Home » Topics » BioWorld Science

BioWorld Science
RSS

N-acetyl-beta-D-glucosaminidase inhibitors identified at Janssen

Aug. 24, 2018

Yangzhou Blue Biomedical Technology Co. patents penicilone derivatives

Aug. 24, 2018

GlaxoSmithKline presents leucine-rich repeat serine/threonine-protein kinase 2 inhibitors

Aug. 24, 2018

Preclinical data and structure described for next-generation TYK2 inhibitor PF-06826647

Aug. 24, 2018

Lenvima approved in Europe as first-line treatment in adults with advanced or unresectable HCC

Aug. 24, 2018

Toca 5 pivotal phase III study of Toca-511/Toca-FC continues without modification

Aug. 24, 2018

Amgen targets the apelin receptor with AMG-986 for heart failure therapy

Aug. 24, 2018

DA-9701 may improve gastric motility in Parkinson's disease patients

Aug. 24, 2018

Liver-targeted prodrug may prove effective in fibrosis

Aug. 24, 2018

KW-6356 affects motor scores in phase II early Parkinson's disease trial

Aug. 24, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...